AWM
DVAX

Abound Wealth Management’s Dynavax Technologies DVAX Stock Holding History

Abound Wealth Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11
Closed -$170 – 1523
2025
Q4 		$170 Hold
11
– – ﹤0.01% 1240
2025
Q3 		$110 Hold
11
– – ﹤0.01% 1292
2025
Q2 		$110 Hold
11
– – ﹤0.01% 1235
2025
Q1 		$143 Sell
11
-5
-31% -$66 ﹤0.01% 1112
2024
Q4 		$205 Hold
16
– – ﹤0.01% 1059
2024
Q3 		$179 Sell
16
-5
-24% -$55 ﹤0.01% 1225
2024
Q2 		$236 Hold
21
– – ﹤0.01% 1060
2024
Q1 		$261 Hold
21
– – ﹤0.01% 1189
2023
Q4 		$294 Buy
+21
New +$292 ﹤0.01% 1170

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Abound Wealth Management's DVAX Position: Q1 2026 in Review

Abound Wealth Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 11 shares — an estimated $170 sold.

Abound Wealth Management first reported a position in DVAX in Q4 2023 and held it in 9 quarters. The position peaked at $294 in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Abound Wealth Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Abound Wealth Management sold 11 Dynavax Technologies shares in Q1 2026, an estimated $170.
  • Abound Wealth Management first reported a position in Dynavax Technologies in Q4 2023 and held it in 9 quarters.
  • Abound Wealth Management's Dynavax Technologies position peaked at $294 in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Abound Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.